OVARIAN STIMULATION USING HUMAN MENOPAUSAL GONADOTROPINS WITH OR WITHOUT LHRH ANALOGS IN A LONG PROTOCOL FOR INVITRO FERTILIZATION - A PROSPECTIVE RANDOMIZED COMPARISON

被引:47
作者
ANTOINE, JM [1 ]
SALATBAROUX, J [1 ]
ALVAREZ, S [1 ]
CORNET, D [1 ]
TIBI, C [1 ]
MANDELBAUM, J [1 ]
PLACHOT, M [1 ]
机构
[1] HOP TENON,DEPT OBSTET & GYNAECOL & BIOL REPROD,4 RUE CHINE,F-75970 PARIS 20,FRANCE
关键词
In-vitro fertilization; LHRH agonists;
D O I
10.1093/oxfordjournals.humrep.a137144
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In order to evaluate the exact role of GnRH agonists, we have undertaken a randomized prospective study comparing two groups of 90 normo-ovulatory patients, aged <38 years and with tubal infertility with no male factor. Luteinizing hormone releasing hormone analogue (DTRP6 administered in a long protocol, for at least 15 days) was associated with human menopausal gonadotrophin (HMG) induction in group I. In group II, stimulation was performed using HMG alone (three ampoules per day in general, from days 2 to 7 of the cycle). Apart from the well known results demonstrated in the literature of a reduced incidence of inadequate responses, an absence of premature luteinization and a greater number of oocytes per retrieval (8.8 ± 4.9 versus 6.8 ± 3.2, P < 0.01 in group II), this study confirms the higher pregnancy rate (21.1 versus 12.2% per cycle and 24.7 versus 17.1% per oocyte retrieval, not significant) and underlines the higher plasma progesterone levels and lower E2/P ratio in group I from D - 1 to D + 5, which could explain a better maturation of the oocytes and the endometrium. © 1990 Oxford University Press.
引用
收藏
页码:565 / 569
页数:5
相关论文
共 32 条
  • [1] Awadalla S.G., Friedman C.I., Chin N.W., Dodds W., Park J.M., Kim M.H., Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins, Fertil. Steril, 48, (1987)
  • [2] Barnes R.B., Scommegna A., Schreiber J.R., Decreased ovarian response to human menopausal gonadotropin caused by subcutaneously administered gonadotropin-releasing hormone agonist, Fertil. Steril, 47, (1987)
  • [3] Belaisch-Allart J., Testart J., Frydman R., Utilization of GnRH agonists for poor responders in an IVF programme, Hum. Reprod, 4, pp. 33-34, (1989)
  • [4] Caspi E., Ron-El R., Golan A., Nachum H., Herman A., Softer Y., Weintraub Z., Results of in-vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-TRP-6-luteinizing hormone-releasing hormone and gonadotropins, Fertil. Steril, 51, pp. 95-99, (1989)
  • [5] Crosignani P.G., Ragni G., Lombroso G.C., Scarduelli C., De L., Caccamo A., Dalpra L., Cavioni V., Cristiani C., Wyssling H., Olivares M.D., Perotti L., Ovarian stimulation of IVF patients: Effects of the reversible hypogonadotrophic state induced by GnRH agonist, Hum. Reprod, 3, pp. 39-41, (1988)
  • [6] De Ziegler D., Cedars M.I., Randle D., Lu J.K.H., Judd H.L., Meldrum D.R., Suppression of the ovary using a gonadotropin-releasing hormone agonist prior to stimulation for oocyte retrieval, Fertil. Steril, 48, pp. 807-810, (1987)
  • [7] De Ziegler D., Cornel C., Hazout A., Fernandez H., Glissant A., Baton C., Belaisch-Allart J., Frydman R., Randomised trial comparing clomiphene citrate-HMG (CC-HMG) and GNRH agonist- HMG (GNRHa-HMG) for IVF. VI, World Congress for In-Vitro Fertilization and Alternate Assisted Reproduction, (1989)
  • [8] Droesch K., Muasher S.J., Brzyski R.G., Jones G.S., Simonetti S., Liu H.C., Rosenwacks Z., Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization, Fertil. Steril, 51, pp. 292-297, (1989)
  • [9] Feldberg D., Ashkenazi J., Dicker D., Yeshaya A., Goldman G.A., Goldman J.A., Ovarian cyst formation: A complication of gonadotropin-releasing hormone agonist therapy, Fertil. Steril, 51, pp. 42-45, (1989)
  • [10] Fleming R., Coutts J., Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression, Fertil. Steril, 45, pp. 226-230, (1986)